Webinars Back to resource centre 11 January 2023 Elderly patients in clinical trials: addressing the evidence-practice gap Despite carrying the largest burden of chronic diseases and taking more prescription medications than any other group, older adults are consistently under-represented in clinical trials. The complex, and therefore risky, treatment needs associated with older adults is often what makes sponsors hesitant to

Webinars Back to resource centre 11 January 2023 Future directions in eCOA: Innovations in high-frequency and automated voice-based testing As drug development programmes increasingly demand real-world data collection – are the current eCOA instruments fit for purpose? Which innovations will change the landscape, what are the challenges and how might we overcome them? In this webinar Chief Technology Officer at

Webinars Back to resource centre 11 January 2023 Pro-cognitive drug trial failures in schizophrenia: the need for cognitive screening? Despite a wealth of research, pharmaceutical companies have thus far been unsuccessful in their attempts to address cognitive impairment in schizophrenia. This begs the question: are these compounds truly ineffective or has trial methodology itself been a limiting factor in successfully